Stephen Liu, Director of Thoracic Oncology, Head of Developmental Therapeutics and Associate Professor at Georgetown Lombardi Comprehensive Cancer Center, posted on X:
“Some great discussions on antibody drug conjugates – including the future of ADCs in NSCLC – in this live webinar from PRIME Education with Benjamin Levy.
Many studies in later lines but does the true promise of these drugs live in the first-line setting?”
